Hepatic encephalopathy (HE) is a major complication and a frequent cause of both initial hospitalization and readmission in cirrhotic patients. It can be difficult to diagnose, as there are no distinctive disease biomarkers, and diagnosis must be made by excluding other causes of neurologic and psychiatric dysfunction.
This CME opportunity features both a podcast series and related journal articles. You’ll learn from gastroenterologists, hepatologists, advanced practice providers, and other critical patient care team members as they address hepatic encephalopathy diagnosis and management practice gaps.
Learning Objectives:
Upon completing the podcast series and the associated journal modules, learners will be able to:
- Discuss the changing epidemiology of cirrhosis and undiagnosed cirrhosis for patients with liver disease.
- Assess guidelines and best practices for HE diagnosis and management.
- Develop transition of care plans with patients, caretakers, and specialty providers after an initial HE diagnosis.
Episodes Sequence:
Episode 1. HE: Current and emerging treatment modalities
Host:
Robert S. Brown, MD, MPH
Chief of the division of gastroenterology and hepatology
Weill Cornell Medicine
Speaker:
Robert Rahimi, MD, MS
Board-Certified Physician
Transplant hepatology, gastroenterology, and internal medicine
Baylor University Medical Center
Episode 2. HE: Changing epidemiology of cirrhosis and hepatic encephalopathy
Host:
Lisa P. Beyers, MD
Assistant professor
Hospital medicine
University of Rochester Medical Center
Speaker:
Elliot Tapper, MD
Associate professor
Division of gastroenterology and hepatology
Director of the Michigan cirrhosis program
University of Michigan
Episode 3. HE: Inadequate practices in the inpatient setting
Host:
Robert S. Brown, MD, MPH
Chief of the division of gastroenterology and hepatology
Weill Cornell Medicine
Speaker:
Lisa P. Beyers, MD
Assistant professor
Hospital medicine
University of Rochester Medical Center
Episode 4. HE: Missed diagnosis of cirrhosis in the inpatient setting
Host:
Robert S. Brown, MD, MPH
Chief of the division of gastroenterology and hepatology
Weill Cornell Medicine
Speaker:
Alpesh N. Amin, MD
Professor of medicine
Executive director of UCI's Hospitalist Program.
The Thomas & Mary Cesario endowed chair
Department of medicine
University of California, Irvine
Episode 5. HE: Strategies to prevent readmissions from inadequate transitions of care
Host:
Robert S. Brown, MD, MPH
Chief of the division of gastroenterology and hepatology
Weill Cornell Medicine
Speaker:
Craig Rosenstengle, MD
Fellow, combined gastroenterology and transplant hepatology pathway
Baylor University Medical Center
Episode 6. HE: Specific challenges in geriatric cirrhosis and HE
Host:
Lisa P. Beyers, MD
Assistant professor
Hospital medicine
University of Rochester Medical Center
Speaker:
Robert S. Brown, MD, MPH
Chief of the division of gastroenterology and hepatology
Weill Cornell Medicine
Released: May 15, 2025
Expires: May 31, 2026
Journal Articles
Explore the related articles provided below and earn more CME credit:
- Current and Emerging Treatment Modalities
- Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
- Inadequate Practices for Hepatic Encephalopathy Management in the Inpatient Setting
- Missed Diagnosis of Cirrhosis in the Inpatient Setting
- Hepatic Encephalopathy and Strategies to Prevent Readmission from Inadequate Transitions of Care
- Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy
Accreditation and designation statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.
CME expiration date: May 31, 2026
Partnership and Sponsorship statement:
This educational program was developed in collaboration with the Society for Hospital Medicine and was supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC.